AAKP Key Correspondence

Public Comments & Correspondence

This section includes public comments & correspondence made by the American Association of Kidney Patients staff or board members individually or in conjunction with other organizations. 

Search Archives

2022

AAKP signs onto letter to ask CMS to preserve access to critically important diagnostics and continued use of ICD-10 NOS codes
April 6, 2022 Jonathan Blum Principal Deputy Administrator and Chief Operating Officer Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Delivered electronically Dear Mr. Blum: The undersigned organizations represent a diverse set of stakeholders interested in preserving access to critically important diagnostics for patients with advanced cancer and are concerned about … Continue reading "AAKP Key Correspondence" Read More

2021

132 Organizations Ask for Key Medicare Part D OOP Reforms in Budget Reconciliation Package
September 9, 2021 Chairman Ron Wyden Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Chairman Frank Pallone House Committee on Energy and Commerce 2125 Rayburn House Office Building Washington, DC 20515 Chairman Richard Neal House Committee on Ways and Means 1102 Longworth House Office Building Washington, DC 20515 Chairman Bobby Scott … Continue reading "AAKP Key Correspondence" Read More
RE: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model; CMS-1749-P
August 31, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health & Human Services 7500 Security Boulevard Baltimore, MD 21244 RE: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage … Continue reading "AAKP Key Correspondence" Read More
AAKP PATIENT IMPACT STATEMENT: FULL FDA APPROVAL OF PFIZER/BIONTECH COVID-19 VACCINE
FOR IMMEDIATE RELEASE:                                                           August 23, 2021                                                                                  FULL FDA APPROVAL OF PFIZER/BIONTECH COVID-19 VACCINE  PATIENT IMPACT STATEMENT AMERICAN ASSOCIATION OF KIDNEY PATIENTS (AAKP) AMERICA’S LARGEST ORGANIZATION OF KIDNEY TRANSPLANT RECIPIENTS ANDLIVING ORGAN DONORS WASHINGTON, D.C. – The American Association of Kidney Patients (AAKP), the largest independent kidney patient organization in the nation, issued a formal statement in support … Continue reading "AAKP Key Correspondence" Read More
AAKP Letter Re: Calcimimetics Drugs 8.12.21
      August 11, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue Southwest Washington, D.C. 20201 Dear Administrator Brooks-LaSure, As the oldest and largest kidney patient organization in the United States, the American Association of Kidney Patients (AAKP) would like to extend our sincere congratulations on your … Continue reading "AAKP Key Correspondence" Read More
NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS
NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS The American Association of Kidney Patients (AAKP), the nation’s largest patient organization representing kidney transplant patients and living organ donors, thanks the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices for their agreement, a short time ago, with the FDA … Continue reading "AAKP Key Correspondence" Read More
Letter to Rep. DelBene re Support of Vascular Graft Research 4.13.21
The Honorable Suzan DelBeneVice Chair of Congressional Caucus on DiabetesU.S. House of RepresentativesWashington, DC 20515 Dear Representative DelBene: As stakeholders in supporting new technologies that enhance health and quality of life for patients suffering from kidney disease, vascular disease, heart disease, and vascular trauma, we are asking for your kind supportof the attached report language … Continue reading "AAKP Key Correspondence" Read More
Letter to Senator Murray re Support of Vascular Graft Research
The Honorable Patty MurrayDefense Appropriations SubcommitteeU.S. SenateWashington, D.C. 20510 Dear Senator Murray: On behalf of of a coalition of concerned Washington State-based stakeholders, I am writing to you to request your support of continued federal research for new synthetic vascular graft technology. I joined this auspicious group of concerned entities and felt that I could … Continue reading "AAKP Key Correspondence" Read More
QALY Coalition Letter 4.21.21
Every life is valuable. We strongly urge policymakers to reject policies that discriminate against people with disabilities and chronic conditions, older adults, and reinforce health inequities. As organizations representing patients and people with disabilities, we call on policymakers to work to ensure the most vulnerable populations among us, including people with disabilities, will not be … Continue reading "AAKP Key Correspondence" Read More
STATEMENT ON COMPREHENSIVE LIVING ORGAN DONOR PROTECTIONS
STATEMENT ON COMPREHENSIVE LIVING ORGAN DONOR PROTECTIONS March is National Kidney Month and April is National Donate Life Month.  As leading, independent, national organizations representing patients, organ donors and their families, transplant surgeons, and transplant health professionals, the American Association of Kidney Patients (AAKP), the American Society of Transplant Surgeons (ASTS), the American Society of … Continue reading "AAKP Key Correspondence" Read More
Older Correspondence

2020

2019

2018

2017

2016

2014

2013

2012

2011

2008

View Archive